Skip to main content

Advertisement

SpringerLink
Log in

Neurologic Manifestations of Lyme Disease

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Borrelia burgdorferi infection, the tick-borne spirochetosis known as Lyme disease or Lyme borreliosis, involves the nervous system (neuroborreliosis) in 10% to 15% of patients. Common manifestations include lymphocytic meningitis, cranial neuritis, mononeuropathy multiplex, and painful radiculoneuritis. Rare patients develop inflammation in the brain or spinal cord. Regardless of the form of involvement, neuroborreliosis can be microbiologically cured in virtually all patients using standard 2- to 4-week antimicrobial regimens. Oral regimens appear to be as effective as parenteral ones in most instances. Although patients ill with Lyme disease may have concomitant cognitive or memory difficulty, these symptoms are not specific to neuroborreliosis and, when present in isolation, should not be viewed as suggestive of this diagnosis. When present as part of Lyme disease, they do not require additional or different treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Afzelius A. Verhandlugen der dermatorischen Gesellshaft zu Stockholm. Arch Dermatol Syph. 1910;101:404.

    Google Scholar 

  2. Garin C, Bujadoux A. Paralysie par les tiques. J Méd Lyon. 1922;71:765–7.

    Google Scholar 

  3. Steere AC, Malawista SE, Hardin JA, et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977;86:685–98.

    PubMed  CAS  Google Scholar 

  4. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme Disease. N Engl J Med. 1983;308:740–2.

    Article  PubMed  CAS  Google Scholar 

  5. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme Disease. N Engl J Med. 1983;308:733–40.

    Article  PubMed  CAS  Google Scholar 

  6. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme Disease—United States, 1992–2006. MMWR Morb Mortal Wkly Rep. 2008;57:1–9.

    Google Scholar 

  7. Steere AC. Diagnosis and treatment of Lyme arthritis. Med Clin North Am. 1997;81:179–94.

    Article  PubMed  CAS  Google Scholar 

  8. Lebech AM, Hansen K, Brandrup F, et al. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn. 2000;5:139–50.

    PubMed  CAS  Google Scholar 

  9. Roux F, Boyer E, Jaulhac B, et al. Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods. Eur J Clin Microbiol Infect Dis. 2007;26:685–93.

    Article  PubMed  CAS  Google Scholar 

  10. Ramesh G, Philipp MT. Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins. Neurosci Lett. 2005;384:112–16.

    Article  PubMed  CAS  Google Scholar 

  11. Ramesh G, Alvarez AL, Roberts ED, et al. Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol. 2003;33:2539–50.

    Article  PubMed  CAS  Google Scholar 

  12. Pachner AR, Amemiya K, Bartlett M, et al. Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-borrelia burgdorferi antibody. Clin Diagn Lab Immunol. 2001;8:225–32.

    PubMed  CAS  Google Scholar 

  13. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2006;43:1089–134.

    Article  PubMed  Google Scholar 

  14. Halperin JJ, Golightly M. Lyme borreliosis in Bell’s palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology. 1992;42:1268–70.

    PubMed  CAS  Google Scholar 

  15. Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology. 1992;42:32–42.

    PubMed  CAS  Google Scholar 

  16. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992;267:1364–7.

    Article  PubMed  CAS  Google Scholar 

  17. • Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 2009;6:42. This study begins to elucidate the sequential immune response involved in the development of symptomatic neuroborreliosis.

  18. Wang ZY, Hansen K, Siden A, Cruz M. Intrathecal synthesis of anti-Borrelia burgdorferi antibodies in neuroborreliosis: a study with special emphasis on oligoclonal IgM antibody bands. Scand J Immunol. 1993;37:369–76.

    Article  PubMed  CAS  Google Scholar 

  19. Hammers Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43:169–75.

    PubMed  CAS  Google Scholar 

  20. Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis - peripheral nervous system manifestations. Brain. 1990;113:1207–21.

    Article  PubMed  Google Scholar 

  21. Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und “rheumatismus”. Arch Psychiatr Nervenkr. 1941;113:284–376.

    Article  Google Scholar 

  22. Reik L, Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine. 1979;58:281–94.

    Article  PubMed  CAS  Google Scholar 

  23. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease. Neurology. 1985;35:47–53.

    PubMed  CAS  Google Scholar 

  24. Halperin J, Logigian E, Finkel M, Pearl R. Practice parameter for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology. 1996;46:619–27.

    PubMed  CAS  Google Scholar 

  25. England JD, Bohm RP, Roberts ED, Philipp MT. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol. 1997;41:375–84.

    Article  PubMed  CAS  Google Scholar 

  26. Kalina P, Decker A, Kornel E, Halperin JJ. Lyme disease of the brainstem. Neuroradiology. 2005;47:903–7.

    Article  PubMed  Google Scholar 

  27. Sibony P, Halperin J, Coyle P, Patel K. Reactive Lyme serology in patients with optic neuritis and papilledema. J Neuro-Ophthalmol. 2005;25:71–82.

    Article  Google Scholar 

  28. Blanc F, Ballonzoli L, Marcel C, et al. Lyme optic neuritis. J Neurol Sci. 2010;295:117–19.

    Article  PubMed  Google Scholar 

  29. Halperin JJ, Pass HL, Anand AK, et al. Nervous system abnormalities in Lyme disease. Ann NY Acad Sci. 1988;539:24–34.

    Article  PubMed  CAS  Google Scholar 

  30. Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology. 1990;40:1340–3.

    PubMed  CAS  Google Scholar 

  31. Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol. 1991;48:1125–9.

    PubMed  CAS  Google Scholar 

  32. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurology. 1992;42:43–50.

    PubMed  CAS  Google Scholar 

  33. Luo N, Johnson J, Shaw J, et al. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078–86.

    Article  PubMed  Google Scholar 

  34. • Cerar D, Cerar T, Ruzic-Sabljic E, et al. Subjective symptoms after treatment of early Lyme disease. Am J Med 2010;123:79–86. This study tracks the evolution of nonspecific symptoms following treatment of early Lyme disease, and shows they occur no more frequently than in healthy controls followed for the same period of time.

  35. • Skogman BH, Croner S, Nordwall M, et al. Lyme Neuroborreliosis in Children; A Prospective Study of Clinical features, Prognosis, and Outcome. Pediatr Infect Dis J 2008;27:1089–94. This study follows children treated for neuroborreliosis and demonstrates that residual subjective symptoms occur no more frequently than in healthy controls.

  36. •• Hassett AL, Radvanski DC, Buyske S, et al. Psychiatric Comorbidity and Other Psychological Factors in Patients with “Chronic Lyme Disease”. Am J Med 2009;122:843–50. This important study begins to identify premorbid personality traits that place individuals at increased risk of persistent symptoms following treatment for Lyme disease, and shows that in the majority of such symptomatic individuals, depression is not a contributing factor.

  37. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1–9.

    PubMed  CAS  Google Scholar 

  38. Johnson BJ. Lyme disease: serologic assays for antibodies to Borrelia burgdorferi. In: Detrick B, Hamilton R, Folds J, editors. Manual of molecular and clinical laboratory immunology. 7th ed. Washington, DC: ASM Press; 2006.

    Google Scholar 

  39. Anonymous: Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995;44:590–591.

    Google Scholar 

  40. Trevejo RT, Krause PJ, Sikand VK, et al. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J Infect Dis. 1999;179:931–8.

    Article  PubMed  CAS  Google Scholar 

  41. Picha D, Moravcova L, Zdarsky E, et al. PCR in lyme neuroborreliosis: a prospective study. Acta Neurol Scand. 2005;112:287–92.

    Article  PubMed  CAS  Google Scholar 

  42. Avery RA, Frank G, Eppes SC. Diagnostic utility of Borrelia burgdorferi cerebrospinal fluid polymerase chain reaction in children with Lyme meningitis. Pediatr Infect Dis J. 2005;24:705–8.

    Article  PubMed  Google Scholar 

  43. Mygland A, Ljostad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(8–16):e11–14.

    Google Scholar 

  44. Klempner MS, Schmid CH, Hu L, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001;110:217–19.

    Article  PubMed  CAS  Google Scholar 

  45. Feder Jr HM, Johnson BJ, O’Connell S, et al. A critical appraisal of “chronic Lyme disease”. N Engl J Med. 2007;357:1422–30.

    Article  PubMed  CAS  Google Scholar 

  46. Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology. 2007;69:91–102.

    Article  PubMed  CAS  Google Scholar 

  47. Lantos PM, Charini WA, Medoff G, et al. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis. 2010;51:1–5.

    Article  PubMed  Google Scholar 

  48. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85–92.

    Article  PubMed  CAS  Google Scholar 

  49. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60:1923–30.

    PubMed  CAS  Google Scholar 

  50. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992–1003.

    Article  PubMed  CAS  Google Scholar 

  51. Halperin JJ. Nervous system Lyme disease. J R Coll Physicians Edinb. 2010;40:248–55.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, Overlook Hospital & Atlantic Health, 99 Beauvoir Avenue, Summit, NJ 07902, USA

    John J. Halperin

Authors
  1. John J. Halperin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John J. Halperin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halperin, J.J. Neurologic Manifestations of Lyme Disease. Curr Infect Dis Rep 13, 360–366 (2011). https://doi.org/10.1007/s11908-011-0184-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-011-0184-x

Keywords

Search

Navigation